Home Compare GSK.L vs LLY
Stock Comparison · Industry comparison · Drug Manufacturers - General

GSK vs Eli Lilly and Company: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Eli Lilly and Company carrying a narrow edge on growth. GSK still leads on valuation and stability, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (GSK.L: STOXX 600, LLY: S&P 500).

Updated 2026-07-05

Most of the lead runs through growth, while profitability helps make the separation broader.

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. GSK.L and LLY share the same industry classification.

For a similarity-based comparison, see how GSK and Eli Lilly and Company each position within their functional peer groups in AssetNext.

Peer-Relative Score
GSK.L
GSK plc
66
Peer-Score
Signal qualitylow
Peer basis: STOXX 600
vs
LLY
Eli Lilly and Company
70
Peer-Score
Signal qualityHigh
Peer basis: S&P 500

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: GSK.L vs LLY Profitability 64 100 Stability 77 34 Valuation 83 43 Growth 31 100 GSK.L LLY
Gap Ranking
#1 Growth +69
#2 Stability +43
#3 Valuation +40
#4 Profitability +36
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for GSK.L and LLY Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer GSK.LLLY Relative valuation Structural strength

Eli Lilly and Company occupies the cheaper side of the setup map, although GSK plc still holds the stronger structural profile.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Eli Lilly and Company ranks near the top of the group on growth; GSK plc sits in the weaker half.
Stability
The same broad pattern appears on stability: GSK plc ranks near the top of the group, while Eli Lilly and Company stays in the weaker half.
Growth — Dominant Gap
GSK.L
31
LLY
100
Gap+69in favour of LLY

Growth adds another layer to the lead, with a very wide gap in revenue growth between the two companies.

What keeps the gap from being one-sided

A meaningful counterforce remains in stability, which keeps the comparison from looking completely one-sided.

What this means for the comparison

Growth gives Eli Lilly and Company the clearer edge, even though stability and the price setup keep the overall picture from looking clean.

Explore full peer positioning in AssetNext

Break down the GSK.L vs LLY comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how GSK.L and LLY each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.